Shares of 22nd Century Group (XXII) jumped 115% in pre-market trading today after the company announced accelerating commercial launches of its VLN® reduced-nicotine cigarettes. The expansion signals strong early traction for the only FDA-authorized combustible cigarette that aligns with the agency’s proposed nationwide nicotine cap.
New partner brands, including Smoker Friendly VLN® and Pinnacle VLN®, are rolling out the ultra-low nicotine product in key U.S. markets. These launches support the FDA’s pending rule to mandate significantly lower nicotine levels in cigarettes, an initiative expected to dramatically reduce smoking rates.
- VLN cigarettes contain 95% less nicotine and average 0.5 mg/g, below the FDA’s proposed 0.7 mg/g limit
- 22nd Century’s tobacco is the only commercially available product that meets the proposed standard
- The company says it can scale production to meet nationwide demand
The FDA’s rule, still under review, could be finalized within two years and is projected to prevent up to 48 million people from starting smoking by 2100. With a ready-to-scale product and commercial partners already deploying VLN cigarettes, 22nd Century is uniquely positioned to lead this public health shift.
The post 22nd Century Shares Soar 115% as VLN Cigarettes Gain Ground in FDA Policy Push appeared first on PRISM MarketView.